TITLE

The developing management of esthesioneuroblastoma: a single institution experience

AUTHOR(S)
Bäck, Leif; Oinas, Minna; Pietarinen-Runtti, Petra; Saarilahti, Kauko; Vuola, Jyrki; Saat, Riste; Öhman, Juha; Haglund, Caj; Niemelä, Mika; Leivo, Ilmo; Hagström, Jaana; Mäkitie, Antti
PUB. DATE
January 2012
SOURCE
European Archives of Oto-Rhino-Laryngology;Jan2012, Vol. 269 Issue 1, p213
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Esthesioneuroblastoma remains a challenging disease because of its rarity, the complexity of surrounding structures, missing opinions of optimal treatment protocol, and complications associated with necessary surgery. Our objective was to analyse the management and outcome of a cohort of patients with esthesioneuroblastoma from 1990 to 2009 in a tertiary medical centre. There were 17 eligible patients (8 males and 9 females) with the median age of 53 years (range 20-75 years). An obvious inconsistency was noted in the management of the various tumours of the present series during the two decades due to a lack of a uniform treatment protocol. The median follow-up time was 57.5 months (range 3-158 months). Nine patients (seven with curative treatment intent) died of the disease with the median time from diagnosis to death of 60 months (range 3-161 months). Eight patients had no evidence of the disease at last follow-up visit (median 76 months, range 24-119 months). Recurrences were documented in seven of the patients. The median time from end of primary treatment to a recurrence was 57 months (range 6-110 months). The 5-year overall survival and disease-free survival was 68 and 62%, respectively. The management of ENB should be planned by an experienced head and neck surgeon as part of a multidisciplinary team in a tertiary referral setting. Multimodality therapy with long-term follow-up is preferable and should be set based on the available disease-specific classifications for clinical staging and histopathological grading.
ACCESSION #
70071823

 

Related Articles

  • Primary Systemic Therapy of Breast Cancer. Sachelarie, Irina; Grossbard, Michael L.; Chadha, Manjeet; Feldman, Sheldon; Ghesani, Munir; Blum, Ronald H. // Oncologist;Jun2006, Vol. 11 Issue 6, p574 

    Primary systemic therapy (PST) or neoadjuvant therapy is used in nonmetastatic breast cancer to treat systemic disease earlier, decrease tumor bulk ideally to a complete pathological response (pCR), and reduce the extent of surgery. The multitude of clinical trials using PST in breast cancer...

  • Ankle Blood Pressure and Pulse Pressure as Predictors of Cerebrovascular Morbidity and Mortality in a Prospective Follow-Up Study. Hietanen, Heikki J.; Pääkkönen, Rauni; Salomaa, Veikko // Stroke Research & Treatment;2010, p1 

    Background and Objective. We examined the association of elevated ankle blood pressure (ABP), together with exercise blood pressure, with incident cerebrovascular (CV) morbidity and mortality in a prospective follow-up study of 3, 808 patients. The results were compared with pulse pressure,...

  • Quality of surgical care, local recurrence, and survival in patients with low- and midrectal cancers following multimodal therapy. Kellokumpu, Ilmo; Vironen, Jaana; Kairaluoma, Matti; Jantunen, Ismo; Kautiainen, Hannu; Nuorva, Kyösti // International Journal of Colorectal Disease;Jan2012, Vol. 27 Issue 1, p111 

    Purpose: To assess the quality of surgical care and outcome following multimodal treatment for low- and midrectal cancers, focusing on differences between low anterior and abdominoperineal resections. Methods: From 1999 to 2007, 179 patients underwent low anterior resection (LAR),...

  • Multidisciplinary Therapy of Locally Far-Advanced or Inflammatory Breast Cancer with Fixed Perioperative Sequence of Epirubicin, Vinorelbine, and Fluorouracil Chemotherapy, Surgery, and Radiotherapy: Long-Term Results. Ardavanis, Alexandros; Scorilas, Andreas; Tryfonopoulos, Dimitrios; Orphanos, Georgios; Missitzis, Ioannis; Karamouzis, Michael; Chrysochoou, Minas; Sotiropoulou, Anastasia; Arnogiannaki, Niki; Ioannidis, Georgios; Pissakas, Georgios; Rigatos, Gerassimas // Oncologist;Jun2006, Vol. 11 Issue 6, p563 

    Background. Based on phase II data in advanced breast cancer (BC), the fluorouracil, epirubicin, andvinorelbine (FEN) combination was assessed as perioperative chemotherapy, integrated in a multidisciplinary treatment for locally advanced BC. Patients and Methods. Patients with newly diagnosed...

  • Traumatic retinopathy presenting as acute macular neuroretinopathy. Nentwich, Martin M.; Leys, Anita; Cramer, Andreas; Ulbig, Michael W. // British Journal of Ophthalmology;Oct2013, Vol. 97 Issue 10, p1268 

    Aim Traumatic retinopathy presenting as acute macular neuroretinopathy (AMNR) is an uncommon disease causing paracentral scotomas after indirect trauma. Methods We report on five patients (six eyes) with AMNR with a temporary reduction of visual acuity and persistent paracentral scotomas after...

  • Outcomes of Gleason Score ≤8 among High Risk Prostate Cancer Treated with 125I Low Dose Rate Brachytherapy Based Multimodal Therapy. Dong Soo Park; In Hyuck Gong; Don Kyung Choi; Jin Ho Hwang; Hyun Soo Shin; Jong Jin Oh // Yonsei Medical Journal;Sep2013, Vol. 54 Issue 5, p1207 

    Purpose: To investigate the role of low dose rate (LDR) brachytherapy-based multimodal therapy in high-risk prostate cancer (PCa) and analyze its optimal indications. Materials and Methods: We reviewed the records of 50 high-risk PCa patients [clinical stage ≥T2c, prostate-specific antigen...

  • Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. Colman, Ian; Murray, Joseph; Abbott, Rosemary A.; Maughan, Barbara; Kuh, Diana; Croudace, Tim J.; Jones, Peter B. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/24/2009, p208 

    Objective: To describe longterm outcomes associated with externalising behaviour in adolescence, defined in this study as conduct problems reported by a teacher, in a population based sample. Design: Longitudinal study from age 13-53. Setting: The Medical Research Council National Survey of...

  • The Impact of Prior Percutaneous Coronary Intervention on Long-Term Survival after Coronary Artery Bypass Grafting. O’Neal, Wesley T.; Efird, Jimmy T.; Anderson, Curtis A.; Kindell, Linda C.; O’Neal, Jason B.; Bruce Ferguson, T.; Randolph Chitwood, W.; Kypson, Alan P. // Heart, Lung & Circulation;Nov2013, Vol. 22 Issue 11, p940 

    Background: Previous studies examining the influence of prior percutaneous coronary intervention (PCI) on long-term survival after coronary artery bypass grafting (CABG) have reported conflicting results. The purpose of this study was to further examine the influence of prior PCI on long-term...

  • Cambridgeshire cataract shared care model: community optometrist-delivered postoperative discharge scheme. Voyatzis, George; Roberts, Harry W.; Keenan, Jonathan; Rajan, Madhavan S. // British Journal of Ophthalmology;Jun2014, Vol. 98 Issue 6, p760 

    Background/aims To evaluate a community optometrist-delivered postoperative discharge scheme in patients who underwent same day discharge from the hospital eye service (HES) following cataract surgery. Methods A service-level agreement (SLA) was agreed between the HES, primary care trust and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics